Try our beta test site
47 studies found for:    Open Studies | "Oropharyngeal Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Dose Escalation Versus Standard in Laryngopharyngeal Cancers
Conditions: Malignant Neoplasm of Oropharynx Stage III;   Malignant Neoplasm of Larynx Stage III;   Malignant Neoplasm of Hypopharynx Stage III;   Malignant Neoplasm of Oropharynx Stage IVa;   Malignant Neoplasm of Oropharynx Stage IVb;   Malignant Neoplasm of Larynx Stage IV;   Malignant Neoplasm of Hypopharynx Stage IVa;   Malignant Neoplasm of Hypopharynx Stage IVb
Interventions: Radiation: Escalated Dose;   Radiation: Standard Dose
22 Not yet recruiting ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment
Conditions: Oral Cavity Neoplasm;   Oropharyngeal Neoplasm;   Stage I Oral Cavity Squamous Cell Carcinoma;   Stage I Oropharyngeal Squamous Cell Carcinoma;   Stage II Oral Cavity Squamous Cell Carcinoma;   Stage II Oropharyngeal Squamous Cell Carcinoma;   Stage III Oral Cavity Squamous Cell Carcinoma;   Stage III Oropharyngeal Squamous Cell Carcinoma;   Stage IVA Oral Cavity Squamous Cell Carcinoma;   Stage IVA Oropharyngeal Squamous Cell Carcinoma;   Stage IVB Oral Cavity Squamous Cell Carcinoma;   Stage IVB Oropharyngeal Squamous Cell Carcinoma;   Stage IVC Oral Cavity Squamous Cell Carcinoma;   Stage IVC Oropharyngeal Squamous Cell Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Metformide Hydrochloride/Pioglitazone Hydrochloride Extended-Release Tablet;   Other: Pharmacological Study;   Other: Placebo
23 Recruiting Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.
Conditions: Oropharyngeal Cancer;   Oral Cancer;   Lymph Node Metastasis
Intervention: Radiation: Radiation therapy
24 Recruiting Swallowing, Speech and Quality of Life of Patients With Carcinoma of the Oropharynx
Condition: Squamous Cell Carcinoma of the Oropharynx
Intervention: Procedure: Ability to swallow, speak and quality of life
25 Recruiting A Pilot Study at a Single-Institution of Pregabalin in the Management of Mucositis Pain in Patients Undergoing Chemoradiation Therapy to the Head and Neck.
Conditions: Oropharyngeal Cancer;   Squamous Cell Carcinoma to the Head and Neck
Intervention: Drug: Lyrica 300 mg
26 Recruiting Adaptative Radiotherapy to Decrease Xerostomia in Oropharynx Carcinoma
Condition: Oropharynx Cancer
Intervention: Radiation: adaptative radiotherapy
27 Recruiting A Phase II Randomized Trial for Early-stage Squamous Cell Carcinoma of the Oropharynx: Radiotherapy vs Trans-oral Robotic Surgery (ORATOR)
Condition: Early-Stage Squamous Cell Carcinoma of the Oropharynx
Interventions: Radiation: Radiotherapy;   Procedure: Transoral Robotic Surgery + Neck Dissection
28 Recruiting A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery
Conditions: Colorectal Neoplasms;   Urologic Neoplasms;   Urologic Diseases;   Nasopharyngeal Neoplasms;   Oropharyngeal Neoplasms;   Oral Neoplasms;   Hypopharyngeal Neoplasms;   Laryngeal Neoplasms;   ENT Diseases
Intervention: Procedure: Robotic single port surgery and NOTES
29 Recruiting Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients
Conditions: Oral Cavity Cancer;   Oropharyngeal Cancer;   Lymphedema;   Fibrosis
Interventions: Other: LEF measures;   Procedure: Technical measure
30 Recruiting Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas
Conditions: Cervical Cancer;   Vulvar Cancer;   Anal Cancer;   Oropharynx Cancer
Intervention: Other: CaptHPV method
31 Not yet recruiting Impact of HPV Vaccine On The Prevalence Of HPV In Norway
Conditions: Cervical Intraepithelial Neoplasia;   Cervical Cancer;   Oropharyngeal Cancer
Interventions: Procedure: Self sample from vagina;   Procedure: Self sample from the oral cavity;   Other: Questionnaire
32 Recruiting HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA
Conditions: Human Papillomavirus-Related Carcinoma;   Human Papillomavirus Positive Oropharyngeal Carcinoma;   Human Papillomavirus Positive Cervical Carcinoma;   Human Papillomavirus Positive Anal Carcinoma;   Human Papillomavirus Positive Vulvar Carcinoma;   Human Papillomavirus Positive Penile Carcinoma
Interventions: Biological: HPV Specific T Cells;   Drug: Cytoxan;   Drug: Fludarabine;   Biological: Nivolumab
33 Recruiting Interest of Narrow Band Imaging in Detection of Upper Aerodigestive Cancers
Conditions: Squamous Cell Carcinoma of Oropharynx;   Squamous Cell Carcinoma of Hypopharynx;   Squamous Cell Carcinoma of Larynx
Intervention: Procedure: WL and NBI
34 Recruiting HPV Serum DNA Levels Predicting Outcome in p16+ Squamous Cell Head and Neck Cancer
Condition: Subjects With p16+/HPV+ Squamous Cell Carcinomas of the Oropharynx.
Intervention: Other: Obtaining Human tissue
35 Recruiting Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer
Conditions: Head and Neck Squamous Cell Carcinoma;   Stage IVA Oropharyngeal Carcinoma;   Stage IVB Oropharyngeal Carcinoma
Interventions: Drug: Carboplatin;   Drug: Cisplatin;   Drug: Fluorouracil;   Drug: Hydroxyurea;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Other: Placebo;   Radiation: Radiation Therapy;   Drug: Veliparib
36 Recruiting Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer
Conditions: Larynx Cancer;   Lip Cancer;   Oral Cavity Cancer;   Pharyngeal Cancer;   Oropharyngeal Cancer
Intervention:
37 Recruiting uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer
Conditions: Oral Cancer;   Oropharyngeal Cancer;   Neoplasms;   Head and Neck Neoplasms;   Cancer of Mouth;   Neoplasms by Site
Intervention: Other: 68Ga-NOTA-AE105 PET/CT
38 Recruiting E7 TCR T Cells With or Without PD-1 Blockade for Human Papillomavirus-Associated Cancers
Conditions: Cervical Cancer;   Vaginal Cancer;   Anal Cancer;   Penile Cancer;   Oropharyngeal Cancer
Interventions: Biological: E7 TCR Transduced PBL cells;   Drug: pembrolizumab;   Drug: aldesleukin;   Drug: fludarabine;   Drug: cyclophosphamide
39 Recruiting Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer
Conditions: Human Papilloma Virus Infection;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Oropharynx
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Drug: carboplatin;   Radiation: radiation therapy;   Drug: paclitaxel;   Drug: fluorouracil;   Drug: hydroxyurea;   Drug: cisplatin;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
40 Recruiting Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer
Conditions: Human Papilloma Virus Infection;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Oropharynx
Interventions: Procedure: therapeutic conventional surgery;   Radiation: intensity-modulated radiation therapy;   Drug: cisplatin;   Drug: carboplatin;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-47) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.